Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)
|
April 27, 2010
Methods to evaluate transporter activity in cancer
Takeo Nakanishi, Douglas D Ross, Keisuke Mitsuoka
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
December 5, 2006
Functional expression of stereoselective metabolism of cephalexin by exogenous transfection of oligopeptide transporter PEPT1
Keisuke Mitsuoka, Yukio Kato, Yoshiyuki Kubo, et al.
American Journal of Physiology. Renal Physiology
|
May 1, 2009
Organic anion transporter OAT1 is involved in renal handling of citrulline
Masanori Nakakariya, Yoichiro Shima, Yoshiyuki Shirasaka, et al.
Biological & Pharmaceutical Bulletin
|
August 5, 2009
Direct evidence for efficient transport and minimal metabolism of L-cephalexin by oligopeptide transporter 1 in budded baculovirus fraction
Keisuke Mitsuoka, Ikumi Tamai, Yasushi Morohashi, et al.
Biopharmaceutics & Drug Disposition
|
March 27, 2009
Transport characteristics of L-citrulline in renal apical membrane of proximal tubular cells
Keisuke Mitsuoka, Yoshiyuki Shirasaka, Akimasa Fukushi, et al.
Nuclear Medicine and Biology
|
July 25, 2018
Predicting response to sepantronium bromide (YM155), a survivin suppressant, by PET imaging with [<sup>11</sup>C]YM155
Keisuke Mitsuoka, Aya Kita, Yoshihiro Murakami, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 23, 2006
Predominant contribution of organic anion transporting polypeptide OATP-B (OATP2B1) to apical uptake of estrone-3-sulfate by human intestinal Caco-2 cells
Yoshimichi Sai, Yosuke Kaneko, Satsuki Ito, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 4, 2014
Combination of YM155, a survivin suppressant, with bendamustine and rituximab: a new combination therapy to treat relapsed/refractory diffuse large B-cell lymphoma
Naoki Kaneko, Keisuke Mitsuoka, Nobuaki Amino, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
March 24, 2010
Inhibition of oligopeptide transporter suppress growth of human pancreatic cancer cells
Keisuke Mitsuoka, Yukio Kato, Sosuke Miyoshi, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
March 5, 2013
[18F]FDG-PET as an imaging biomarker to NMDA receptor antagonist-induced neurotoxicity
Takafumi Shirakawa, Keisuke Mitsuoka, Kanae Kuroda, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Methods in Molecular Biology (Clifton, N.J.)
|
April 27, 2010
Methods to evaluate transporter activity in cancer
Takeo Nakanishi, Douglas D Ross, Keisuke Mitsuoka
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
December 5, 2006
Functional expression of stereoselective metabolism of cephalexin by exogenous transfection of oligopeptide transporter PEPT1
Keisuke Mitsuoka, Yukio Kato, Yoshiyuki Kubo, et al.
American Journal of Physiology. Renal Physiology
|
May 1, 2009
Organic anion transporter OAT1 is involved in renal handling of citrulline
Masanori Nakakariya, Yoichiro Shima, Yoshiyuki Shirasaka, et al.
Biological & Pharmaceutical Bulletin
|
August 5, 2009
Direct evidence for efficient transport and minimal metabolism of L-cephalexin by oligopeptide transporter 1 in budded baculovirus fraction
Keisuke Mitsuoka, Ikumi Tamai, Yasushi Morohashi, et al.
Biopharmaceutics & Drug Disposition
|
March 27, 2009
Transport characteristics of L-citrulline in renal apical membrane of proximal tubular cells
Keisuke Mitsuoka, Yoshiyuki Shirasaka, Akimasa Fukushi, et al.
Nuclear Medicine and Biology
|
July 25, 2018
Predicting response to sepantronium bromide (YM155), a survivin suppressant, by PET imaging with [<sup>11</sup>C]YM155
Keisuke Mitsuoka, Aya Kita, Yoshihiro Murakami, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 23, 2006
Predominant contribution of organic anion transporting polypeptide OATP-B (OATP2B1) to apical uptake of estrone-3-sulfate by human intestinal Caco-2 cells
Yoshimichi Sai, Yosuke Kaneko, Satsuki Ito, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 4, 2014
Combination of YM155, a survivin suppressant, with bendamustine and rituximab: a new combination therapy to treat relapsed/refractory diffuse large B-cell lymphoma
Naoki Kaneko, Keisuke Mitsuoka, Nobuaki Amino, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
March 24, 2010
Inhibition of oligopeptide transporter suppress growth of human pancreatic cancer cells
Keisuke Mitsuoka, Yukio Kato, Sosuke Miyoshi, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
March 5, 2013
[18F]FDG-PET as an imaging biomarker to NMDA receptor antagonist-induced neurotoxicity
Takafumi Shirakawa, Keisuke Mitsuoka, Kanae Kuroda, et al.
Page
of 2